XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021   127,647      
Beginning balance at Dec. 31, 2021 $ 381,535 $ 128 $ 539,423 $ (237) $ (157,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)   35,714      
Issuance of common stock 205,296 $ 35 205,261    
Share repurchase (in shares)   (130)      
Share repurchase (1,049)   (1,049)    
Equity-based compensation (in shares)   3      
Equity-based compensation 3,171   3,171    
Unrealized gain (loss) on available for sale debt securities (340)     (340)  
Net income (loss) (25,432)       (25,432)
Ending balance (in shares) at Mar. 31, 2022   163,234      
Ending balance at Mar. 31, 2022 563,181 $ 163 746,806 (577) (183,211)
Beginning balance (in shares) at Dec. 31, 2021   127,647      
Beginning balance at Dec. 31, 2021 381,535 $ 128 539,423 (237) (157,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (75,384)        
Ending balance (in shares) at Sep. 30, 2022   163,509      
Ending balance at Sep. 30, 2022 518,537 $ 164 752,559 (1,023) (233,163)
Beginning balance (in shares) at Mar. 31, 2022   163,234      
Beginning balance at Mar. 31, 2022 563,181 $ 163 746,806 (577) (183,211)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share repurchase (in shares)   (2)      
Share repurchase (17)   (17)    
Equity-based compensation (in shares)   50      
Equity-based compensation 3,267   3,267    
Unrealized gain (loss) on available for sale debt securities (460)     (460)  
Net income (loss) (15,004)       (15,004)
Ending balance (in shares) at Jun. 30, 2022   163,282      
Ending balance at Jun. 30, 2022 550,967 $ 163 750,056 (1,037) (198,215)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share repurchase (in shares)   (71)      
Share repurchase (506)   (506)    
Equity-based compensation (in shares)   298      
Equity-based compensation 3,010 $ 1 3,009    
Unrealized gain (loss) on available for sale debt securities 14     14  
Net income (loss) (34,948)       (34,948)
Ending balance (in shares) at Sep. 30, 2022   163,509      
Ending balance at Sep. 30, 2022 $ 518,537 $ 164 752,559 (1,023) (233,163)
Beginning balance (in shares) at Dec. 31, 2022 163,550 163,550      
Beginning balance at Dec. 31, 2022 $ 510,883 $ 164 753,885 (641) (242,525)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share repurchase (in shares)   (48)      
Share repurchase (277)   (277)    
Equity-based compensation (in shares)   169      
Equity-based compensation 2,166   2,166    
Unrealized gain (loss) on available for sale debt securities 641     641  
Net income (loss) (25,842)       (25,842)
Ending balance (in shares) at Mar. 31, 2023   163,671      
Ending balance at Mar. 31, 2023 $ 487,571 $ 164 755,774 0 (268,367)
Beginning balance (in shares) at Dec. 31, 2022 163,550 163,550      
Beginning balance at Dec. 31, 2022 $ 510,883 $ 164 753,885 (641) (242,525)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (77,532)        
Ending balance (in shares) at Sep. 30, 2023 164,059 164,059      
Ending balance at Sep. 30, 2023 $ 441,566 $ 164 761,466 (7) (320,057)
Beginning balance (in shares) at Mar. 31, 2023   163,671      
Beginning balance at Mar. 31, 2023 487,571 $ 164 755,774 0 (268,367)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share repurchase (in shares)   (9)      
Share repurchase (27)   (27)    
Forfeiture of restricted stock (in shares)   (1)      
Equity-based compensation (in shares)   135      
Equity-based compensation 3,252   3,252    
Net income (loss) (56,576)       (56,576)
Ending balance (in shares) at Jun. 30, 2023   163,796      
Ending balance at Jun. 30, 2023 434,220 $ 164 758,999 0 (324,943)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share repurchase (in shares)   (78)      
Share repurchase (818)   (818)    
Equity-based compensation (in shares)   341      
Equity-based compensation 3,285   3,285    
Unrealized gain (loss) on available for sale debt securities (7)     (7)  
Net income (loss) $ 4,886       4,886
Ending balance (in shares) at Sep. 30, 2023 164,059 164,059      
Ending balance at Sep. 30, 2023 $ 441,566 $ 164 $ 761,466 $ (7) $ (320,057)